Suppr超能文献

检测 JAK2 基因外显子 12 突变:使用夹式 PCR 和核苷酸测序提高分析灵敏度。

Detection of exon 12 Mutations in the JAK2 gene: enhanced analytical sensitivity using clamped PCR and nucleotide sequencing.

机构信息

Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, 601 Elmwood Ave, Box 626, Rochester, NY 14642, USA.

出版信息

J Mol Diagn. 2010 May;12(3):278-82. doi: 10.2353/jmoldx.2010.090177. Epub 2010 Mar 4.

Abstract

JAK2 V617F is the most frequently found somatic mutation in polycythemia vera (PV). Among the cases negative for V617F, a significant fraction have a mutation in exon 12 of the JAK2 gene. Several groups have reported that the exon 12 mutations are present in only a small fraction of the blood cells in some patients. We have developed an assay to detect these mutations with an analytical sensitivity of 0.1% by using a "PCR clamp" to inhibit amplification of the normal sequence and enhance amplification of DNA containing a mutation in the clamp target sequence. The products of this reaction were analyzed by capillary electrophoresis to detect deletions, which are the most frequent type of exon 12 mutations, or by nucleotide sequencing to detect all of the mutations. In a survey of 34 specimens from patients with PV or idiopathic erythrocytosis who did not have a JAK2 V617F mutation, we found four with a mutation in exon 12, 3 of 10 with PV, and 1 of 24 with idiopathic erythrocytosis. In two cases the mutation was present in a small fraction of the cells and difficult to detect without the use of the clamp. The use of an assay with increased analytical sensitivity enhances the ability to identify patients with mutations in exon 12 of the JAK2 gene.

摘要

JAK2 V617F 是最常见的真性红细胞增多症(PV)体细胞突变。在 V617F 阴性的病例中,相当一部分存在 JAK2 基因外显子 12 的突变。有几个研究组报道,在一些患者的血液细胞中,只有一小部分存在外显子 12 突变。我们开发了一种检测方法,通过使用“PCR 夹”抑制正常序列的扩增并增强夹目标序列中含有突变的 DNA 的扩增,从而将分析灵敏度提高到 0.1%。通过毛细管电泳分析该反应的产物来检测缺失,这是最常见的外显子 12 突变类型,或者通过核苷酸测序来检测所有的突变。在对 34 份未发生 JAK2 V617F 突变的 PV 或特发性红细胞增多症患者的标本进行调查时,我们发现 4 份存在外显子 12 突变,其中 3 份来自 PV 患者,24 份来自特发性红细胞增多症患者。在两种情况下,该突变存在于一小部分细胞中,如果不使用夹,很难检测到。使用具有更高分析灵敏度的检测方法增强了识别 JAK2 基因外显子 12 突变患者的能力。

相似文献

8
Analysis of JAK2V617F mutation in Jordanian patients with myeloproliferative neoplasms.约旦骨髓增殖性肿瘤患者中JAK2V617F突变的分析。
Hematol Oncol Stem Cell Ther. 2015 Dec;8(4):160-6. doi: 10.1016/j.hemonc.2015.07.004. Epub 2015 Aug 1.

引用本文的文献

2
Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview.骨髓增殖性肿瘤与JAK/STAT信号通路:概述
Rev Bras Hematol Hemoter. 2015 Sep-Oct;37(5):348-53. doi: 10.1016/j.bjhh.2014.10.001. Epub 2015 Jun 9.

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验